Clinical Trial Update: A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating 18F-AzaFol as a diagnostic tool for giant cell arteritis (a form of large vessel vasculitis) and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Arteritis

Drugs mentioned

• 18F-AzaFol

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Giant Cell Arteritis | Phase 2 | Status: RECRUITING